C-ABL-IN-5

CAT:

931-T79716-01

Size:

5 mg

Price:

Ask

Target:
Bcr-Abl
Related Pathways:
Tyrosine Kinase/Adaptors|||Cytoskeletal Signaling|||Angiogenesis
Bioactivity:
C-ABL-IN-5, a selective c-Abl inhibitor, exhibits neuroprotective properties and has favorable characteristics including blood-brain barrier permeability, metabolic stability, and pharmacokinetic profiles. When labeled with [18F] (compound [18F]3), C-ABL-IN-5 serves as a tracer in positron emission tomography (PET) scans to assess disease-modifying effects, particularly in research on neurodegenerative conditions like Parkinson's disease (PD) [1].
Molecular Formula:
C19H17F2N3O
Molecular Weight:
341.35
Shipping Conditions:
Cool pack
Storage Temperature:
-20°C

Related Products

CAT	Name
T79716-01	C-ABL-IN-5
T63332-01	BCR-ABL-IN-5
T209171-01	C-ABL-IN-6
T61546-01	C-ABL-IN-3
T39827	C-ABL-IN-1
T62065-01	C-ABL-IN-4
T61128-01	C-ABL-IN-2
TMAB-03534-01	Anti-c-Abl Polyclonal Antibody
T63297-01	ABL-L
TMAB-10427-01	Anti-Phospho-c-Abl (Ser569) Polyclonal Antibody

CAT	Name
MBS5821377	c-ABL-IN-5
HY-156102	c-ABL-IN-5
MBS8577224-01	c-Abl
E8ER1905-29	C-Abl
MBS5806001	BCR-ABL-IN-5
HY-150566	BCR-ABL-IN-5
MBS6405079-01	ABL1 (ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl) (AP)
MBS6405082-01	ABL1 (ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl) (FITC)
MBS6405089-01	ABL1 (ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl) (PE)
MBS6405080-01	ABL1 (ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl) (APC)